DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,593,342 | +6.1% | 107,188 | +2.7% | 0.30% | 0.0% |
| Q2 2023 | $25,054,560 | -41.6% | 104,394 | -38.7% | 0.30% | -41.3% |
| Q1 2023 | $42,887,630 | -6.4% | 170,162 | -1.4% | 0.51% | +6.9% |
| Q4 2022 | $45,797,424 | +20.4% | 172,547 | +17.2% | 0.48% | +15.9% |
| Q3 2022 | $38,029,000 | +0.5% | 147,241 | -1.4% | 0.41% | +8.2% |
| Q2 2022 | $37,856,000 | -58.1% | 149,324 | -51.5% | 0.38% | -57.0% |
| Q1 2022 | $90,315,000 | +32.5% | 307,896 | +48.6% | 0.88% | +38.7% |
| Q4 2021 | $68,172,000 | +615.1% | 207,205 | +561.7% | 0.64% | +674.4% |
| Q3 2021 | $9,533,000 | -17.7% | 31,316 | -27.5% | 0.08% | -6.8% |
| Q2 2021 | $11,584,000 | +215.6% | 43,166 | +164.7% | 0.09% | +183.9% |
| Q1 2021 | $3,671,000 | +6.8% | 16,310 | +5.4% | 0.03% | +24.0% |
| Q4 2020 | $3,438,000 | +199.5% | 15,478 | +86.5% | 0.02% | +47.1% |
| Q1 2020 | $1,148,000 | -90.9% | 8,300 | -89.9% | 0.02% | -88.4% |
| Q4 2019 | $12,659,000 | -28.4% | 82,482 | -32.6% | 0.15% | -34.4% |
| Q3 2019 | $17,685,000 | +1138.4% | 122,452 | +1125.4% | 0.22% | +1078.9% |
| Q2 2019 | $1,428,000 | -78.6% | 9,993 | -83.7% | 0.02% | -75.6% |
| Q3 2018 | $6,673,000 | – | 61,416 | +6141500.0% | 0.08% | – |
| Q2 2018 | $0 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
| Q3 2017 | $523,000 | -86.4% | 6,100 | -86.4% | 0.01% | -90.0% |
| Q1 2017 | $3,848,000 | -34.5% | 45,000 | -40.0% | 0.06% | -31.8% |
| Q3 2016 | $5,879,000 | -39.7% | 75,000 | -22.3% | 0.09% | -40.5% |
| Q2 2016 | $9,747,000 | +794.2% | 96,512 | +739.2% | 0.15% | +377.4% |
| Q1 2016 | $1,090,000 | -85.3% | 11,500 | -85.6% | 0.03% | -80.6% |
| Q4 2015 | $7,414,000 | +741300.0% | 79,918 | +107897.3% | 0.16% | – |
| Q3 2015 | $1,000 | -99.8% | 74 | -98.8% | 0.00% | -100.0% |
| Q2 2015 | $529,000 | -84.6% | 6,249 | -84.6% | 0.01% | -82.6% |
| Q1 2015 | $3,441,000 | +68720.0% | 40,587 | +35502.6% | 0.07% | – |
| Q4 2014 | $5,000 | -91.8% | 114 | -47.7% | 0.00% | -100.0% |
| Q3 2014 | $61,000 | -29.9% | 218 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $87,000 | +31.8% | 218 | -14.5% | 0.00% | +100.0% |
| Q1 2014 | $66,000 | +560.0% | 255 | +672.7% | 0.00% | – |
| Q4 2013 | $10,000 | +400.0% | 33 | +106.2% | 0.00% | – |
| Q3 2013 | $2,000 | +100.0% | 16 | 0.0% | 0.00% | – |
| Q2 2013 | $1,000 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |